Your browser is no longer supported. Please, upgrade your browser.
Settings
CEMI Chembio Diagnostics, Inc. daily Stock Chart
CEMI [NASD]
Chembio Diagnostics, Inc.
Index- P/E- EPS (ttm)-0.50 Insider Own2.70% Shs Outstand17.19M Perf Week3.68%
Market Cap121.19M Forward P/E- EPS next Y-0.36 Insider Trans8.16% Shs Float15.25M Perf Month25.89%
Income-6.70M PEG- EPS next Q-0.17 Inst Own35.20% Short Float0.55% Perf Quarter-28.06%
Sales31.80M P/S3.81 EPS this Y58.80% Inst Trans-13.50% Short Ratio0.74 Perf Half Y-36.49%
Book/sh1.39 P/B5.07 EPS next Y29.40% ROA-26.10% Target Price12.00 Perf Year-19.43%
Cash/sh0.40 P/C17.82 EPS next 5Y-0.27% ROE-34.10% 52W Range4.85 - 11.55 Perf YTD24.56%
Dividend- P/FCF- EPS past 5Y-46.30% ROI-48.40% 52W High-40.17% Beta1.80
Dividend %- Quick Ratio2.10 Sales past 5Y-1.30% Gross Margin36.30% 52W Low42.47% ATR0.30
Employees165 Current Ratio2.90 Sales Q/Q23.70% Oper. Margin-21.50% RSI (14)64.66 Volatility4.01% 5.65%
OptionableNo Debt/Eq0.02 EPS Q/Q-243.80% Profit Margin-21.00% Rel Volume0.16 Prev Close7.05
ShortableYes LT Debt/Eq0.01 EarningsFeb 07 AMC Payout- Avg Volume113.42K Price6.91
Recom1.50 SMA2013.79% SMA5011.15% SMA200-22.25% Volume10,429 Change-1.99%
Dec-19-18Initiated Dougherty & Company Buy
Aug-11-16Reiterated The Benchmark Company Speculative Buy $10 → $9
Apr-18-16Reiterated The Benchmark Company Speculative Buy $6 → $8
Nov-04-15Initiated The Benchmark Company Speculative Buy $6
Sep-10-13Resumed The Benchmark Company Speculative Buy $7
Jan-17-19 04:10PM  Chembio Diagnostics Announces 2019 Analyst and Investor Meeting GlobeNewswire
Jan-07-19 07:00AM  Chembio Diagnostics Receives CE Mark for Point-of-Care Diagnostic Test  Developed in Collaboration with AstraZeneca GlobeNewswire +8.17%
Jan-01-19 02:49PM  Chembio Diagnostics, Inc.s (NASDAQ:CEMI) Path To Profitability Simply Wall St.
Dec-06-18 08:00AM  Chembios French Partner AAZ-LMB Wins Prix Galien International for Best Medical Technology with autotest VIH® GlobeNewswire
Nov-29-18 04:30PM  CEMI: Record YTD Revenue, Margin Improvement Should Soon Follow Zacks Small Cap Research
Nov-19-18 05:00AM  Edited Transcript of CEMI earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-13-18 08:20AM  Factors of Influence in 2018, Key Indicators and Opportunity within Sun Hydraulics, FIS, TRACON Pharmaceuticals, Kona Grill, Endava PLC Sponsored ADR, and Chembio Diagnostics New Research Emphasizes Economic Growth GlobeNewswire -7.04%
Nov-09-18 11:14AM  Chembio Ebola Virus Diagnostic Test Receives U.S. FDA Emergency Use Authorization GlobeNewswire -6.48%
08:00AM  Chembio to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-08-18 04:18PM  Chembio Diagnostics Reports Third Quarter 2018 Financial Results GlobeNewswire
Nov-01-18 07:00AM  Chembio Diagnostics Announces Pricing of its Public Offering of Common Stock GlobeNewswire -11.19%
Oct-31-18 04:05PM  Chembio Diagnostics Announces Proposed Public Offering of Common Stock GlobeNewswire
08:00AM  Chembio to Report Third Quarter 2018 Financial Results on November 8, 2018 GlobeNewswire
Oct-25-18 08:00AM  Chembio Determines Not to Proceed with Proposed Public Offering of Common Stock GlobeNewswire +10.44%
Oct-22-18 05:27PM  Chembio Announces Proposed Public Offering of Common Stock GlobeNewswire
04:38PM  Chembio Reports Preliminary Third Quarter 2018 Revenue GlobeNewswire
Oct-17-18 07:00AM  EXPLAINER-Why its so hard to diagnose Zika Reuters
01:00AM  EXPLAINER-Why its so hard to diagnose Zika Reuters
Oct-16-18 07:00AM  Chembio Receives $10.5 Million Commitment from Bio-Manguinhos for Production of DPP® Assays in Brazil GlobeNewswire
Sep-19-18 09:47AM  Is Chembio Diagnostics Inc (NASDAQ:CEMI) A Cash Cow? Simply Wall St.
Aug-23-18 03:45AM  Edited Transcript of CEMI earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-20-18 12:45PM  CEMI: Ethiopian Tender, Bio-Manguinhos Order Propel Q2 Product Sales. More Revenue Catalysts Emerge. Zacks Small Cap Research
Aug-08-18 04:06PM  Chembio Diagnostics Appoints Dr. Mary Lake Polan to its Board of Directors GlobeNewswire
04:01PM  Chembio Diagnostics Reports Second Quarter 2018 Financial Results GlobeNewswire
02:30PM  Chembio Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Jul-28-18 08:00AM  Chembio Diagnostics Announces Collaboration with FIND to Develop Hepatitis C Virus Point-of-Care Diagnostic Test GlobeNewswire
Jul-26-18 04:05PM  Chembio Diagnostics to Participate in the Canaccord Genuity Growth Conference GlobeNewswire
Jul-25-18 04:05PM  Chembio Diagnostics to Report Second Quarter 2018 Financial Results on August 8, 2018 GlobeNewswire
Jul-19-18 08:00AM  Chembio Diagnostics Appoints Christine Rousseau, Ph.D. as Vice President, Corporate Development GlobeNewswire
May-24-18 08:00AM  Chembio Diagnostics Announces Agreement with Bio-Manguinhos to Commercialize Point-of-Care Tests for Dengue, Zika and Chikungunya in Brazil GlobeNewswire
May-22-18 08:00AM  Chembio Diagnostics and Massachusetts General Hospital Enter Memorandum Of Understanding to Develop Point-of-Care Fever Diagnostic Test GlobeNewswire
May-16-18 08:00AM  Chembio Diagnostics Names John Potthoff, Ph.D. to its Board of Directors GlobeNewswire
May-14-18 07:51PM  Edited Transcript of CEMI earnings conference call or presentation 9-May-18 8:30pm GMT Thomson Reuters StreetEvents
10:20AM  CEMI: Q1 2018: Product Sales Off To Strong Start, And Should Steepen From Here Zacks Small Cap Research
May-09-18 04:11PM  Chembio Diagnostics Reports First Quarter 2018 Financial Results GlobeNewswire
09:55AM  Should You Buy Chembio Diagnostics Inc (NASDAQ:CEMI) At $7.95? Simply Wall St.
Apr-27-18 07:30AM  Wired News Chembio Signs Collaboration Agreement with LumiraDx to Develop New Point-of-Care Diagnostic Tests ACCESSWIRE
Apr-26-18 04:05PM  Chembio Diagnostics to Report First Quarter 2018 Financial Results on May 9, 2018 GlobeNewswire
Apr-25-18 08:00AM  Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases GlobeNewswire
Mar-30-18 03:16AM  Edited Transcript of CEMI earnings conference call or presentation 8-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-14-18 04:30PM  CEMI: Q4 2017: Strategic Successes and Recent Wins Sets Up 2018 To Be Another Strong Year Zacks Small Cap Research
Mar-08-18 04:05PM  Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
12:45PM  Chembio Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Feb-22-18 05:59PM  Chembio Diagnostics to Report Fourth Quarter and 2017 Financial Results on March 8, 2018 GlobeNewswire
Feb-09-18 07:00AM  Chembio Diagnostics Announces Pricing of its Public Offering of Common Stock GlobeNewswire -7.10%
Feb-08-18 05:15PM  Chembio Diagnostics Announces Proposed Public Offering of Common Stock GlobeNewswire
05:02PM  Chembio Diagnostics Announces Major New Tender Win and Certain Preliminary 2017 Financial Results GlobeNewswire
Dec-28-17 11:55AM  ETFs with exposure to Chembio Diagnostics, Inc. : December 28, 2017 Capital Cube
Dec-27-17 08:44AM  Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube
Dec-21-17 08:50AM  Chembio Diagnostics Announces Completion of U.S. Clinical Trial Evaluating DPP® HIV-Syphilis System GlobeNewswire
Dec-20-17 08:50AM  Chembio Diagnostics Announces Appointment of Neil A. Goldman as Chief Financial Officer GlobeNewswire
Dec-19-17 08:50AM  Chembio Diagnostics and AstraZeneca Enter a Collaboration to Develop Point-of-Care Diagnostic Test GlobeNewswire
Dec-07-17 09:00AM  CEMI: Moving PT to $15.5/Share On Upward Revenue Revisions, Comp Multiple Expansion Zacks Small Cap Research
Dec-05-17 08:50AM  Chembio Receives $8.5 Million Commitment from Bio-Manguinhos to Purchase Components for Production of DPP® Assays in Brazil during 2018 GlobeNewswire
Nov-28-17 08:50AM  Chembio Diagnostics Awarded UNICEF Contract to Supply Point-of-Care DPP® Zika Assays and DPP® Micro Readers GlobeNewswire
Nov-20-17 09:00AM  CEMI: DPP HIV/Syph, Several DPP Fever Products to Drive 2018 Growth Zacks Small Cap Research
Nov-09-17 12:20PM  ETFs with exposure to Chembio Diagnostics, Inc. : November 9, 2017 Capital Cube
Nov-08-17 09:03PM  Edited Transcript of CEMI earnings conference call or presentation 8-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
04:15PM  Chembio Diagnostics Reports Third Quarter 2017 Financial Results GlobeNewswire
01:00PM  CHEMBIO DIAGNOSTICS, INC. to Host Earnings Call ACCESSWIRE
Nov-07-17 04:10PM  Investor Network Invites You to the Chembio 2017 Third Quarter Earnings Conference Call and Webcast Live on Wednesday, November 8, 2017 ACCESSWIRE +6.67%
Nov-01-17 08:50AM  Chembio to Host Conference Call to Discuss Third Quarter 2017 Financial Results GlobeNewswire
Oct-30-17 11:33AM  ETFs with exposure to Chembio Diagnostics, Inc. : October 30, 2017 Capital Cube
Oct-17-17 09:37AM  ETFs with exposure to Chembio Diagnostics, Inc. : October 17, 2017 Capital Cube
Oct-05-17 10:55AM  ETFs with exposure to Chembio Diagnostics, Inc. : October 5, 2017 Capital Cube
Oct-04-17 09:25AM  Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017 Capital Cube
Sep-28-17 08:50AM  Chembio Diagnostics Receives FDA Emergency Use Authorization for the First Rapid Zika IgM Test GlobeNewswire
Aug-17-17 05:00PM  Chembio Diagnostics Announces Retirement of Chief Financial Officer GlobeNewswire
Aug-16-17 10:25PM  Edited Transcript of CEMI earnings conference call or presentation 9-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-17 04:15PM  Chembio Diagnostics Reports Second Quarter 2017 Financial Results GlobeNewswire
12:10PM  Investor Network: CHEMBIO DIAGNOSTICS, INC. to Host Earnings Call ACCESSWIRE
Aug-08-17 04:05PM  Investor Network Invites You to the Chembio 2017 Second Quarter Earnings Conference Call and Webcast Live on Wednesday, August 9, 2017 ACCESSWIRE
Aug-03-17 08:50AM  Chembio to Host Conference Call to Discuss Second Quarter 2017 Financial Results GlobeNewswire
Jul-06-17 08:50AM  Gail S. Page Joins Chembio Diagnostics Board of Directors GlobeNewswire
Jul-05-17 08:50AM  Chembios DPP® Zika System Including the DPP® Micro Reader Approved by Brazils Health Regulatory Agency GlobeNewswire
Jun-27-17 04:30PM  Chembio Diagnostics Announces At-The-Market Program GlobeNewswire
Jun-16-17 03:33PM  ETFs with exposure to Chembio Diagnostics, Inc. : June 16, 2017 Capital Cube
Jun-14-17 09:38AM  Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube
Jun-09-17 04:20PM  Edited Transcript of CEMI earnings conference call or presentation 9-May-17 8:30pm GMT Thomson Reuters StreetEvents
Jun-02-17 08:15AM  Blog Coverage Chembio Announces Major Leadership Shuffle as CEO Sperzel Takes Medical Leaves Accesswire
May-18-17 12:00PM  CEMI New Strategy Paying Dividends As Product Sales Bounce Back Zacks Small Cap Research
May-10-17 07:50AM  Edited Transcript of CEMI earnings conference call or presentation 9-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-09-17 04:10PM  Chembio Diagnostics Reports First Quarter 2017 Financial Results GlobeNewswire
01:30PM  Investor Network: CHEMBIO DIAGNOSTICS, INC. to Host Earnings Call Accesswire
May-08-17 04:05PM  Investor Network Invites You to the Chembio 2017 First Quarter Earnings Conference Call and Webcast Live on Tuesday, May 9, 2017 Accesswire
May-03-17 08:50AM  Chembio Secures $5.8 Million Bio-Manguinhos Order to Supply Components for Production of DPP® HIV 1/2 Assay in Brazil GlobeNewswire
May-02-17 08:50AM  Chembio to Host Conference Call to Discuss First Quarter 2017 Financial Results GlobeNewswire
Apr-05-17 04:29PM  ETFs with exposure to Chembio Diagnostics, Inc. : April 5, 2017 Capital Cube
Apr-04-17 08:50AM  Chembio and FIND Collaborate to Develop Point-of-Care Multiplex Test for Acute Febrile Illnesses in Asia Pacific GlobeNewswire
Mar-17-17 12:03PM  Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Capital Cube
Mar-15-17 01:53PM  Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017 Capital Cube
Mar-11-17 01:04PM  CHEMBIO DIAGNOSTICS, INC. Financials
Mar-10-17 11:15AM  CEMI: Surprise Rebound In Lateral Flow, Expect DPP Strong Showing In 2017 Zacks Small Cap Research
Mar-07-17 04:10PM  Chembio Diagnostics Reports 2016 Financial Results GlobeNewswire
04:04PM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 10-K, Annual Report
04:03PM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
07:07AM  Q4 2016 Chembio Diagnostics Inc Earnings Release - After Market Close
Mar-06-17 04:05PM  Investor Network Invites You to the Chembio 2016 Year-End Earnings Conference Call and Webcast Live on Tuesday, March 7, 2017 Accesswire
Feb-28-17 10:00AM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Feb-27-17 08:50AM  Chembio to Host Conference Call to Discuss 2016 Financial Results GlobeNewswire
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or monitor diseases. It offers tests for HIV and Syphilis, and Zika virus. The company also develops tests for malaria, Dengue virus, chikungunya virus, Ebola, Lassa, Marburg, leptospirosis, Rickettsia typhi, Burkholderia pseudomallei, and Orientia tsutsugamushi. It sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, or DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with Concussion Science Group Division of Perseus Science Group LLC for the development of a POC diagnostic test for traumatic brain injury; international diagnostics company to develop a POC diagnostic test for a specific type of cancer; and AstraZeneca for the development of a POC assay for a novel biomarker, as well as with LumiraDx to develop POC diagnostic tests. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Potthoff John GaryDirectorNov 14Buy5.8120,000116,15027,772Nov 16 04:41 PM
Passas RobertSee RemarksNov 05Buy6.7515,000101,25015,000Nov 06 09:00 AM
Esfandiari JavanChief Science/Tech OfficerJun 13Option Exercise5.6420,000112,800111,258Jun 15 12:47 PM
Klugewicz Sharon WPresident, AmericasMay 16Option Exercise4.505,00022,50021,448May 18 12:55 PM
Meller GaryDirectorFeb 26Option Exercise3.4836,875128,325151,875Feb 27 10:04 AM
Goldman Neil AEVP & Chief Financial OfficerFeb 13Buy6.7514,815100,00114,815Feb 13 02:40 PM